Krebs Biochemicals and Industries Ltd
KREBSBIOKrebs Biochemicals and Industries Ltd
KREBSBIO
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -10.36 | 6.70 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 46.01 | 6.09 | 0.55% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Krebs Biochemicals and Industries Limited is engaged in the business of manufacture of active pharmaceutical ingredients. The Company is producing a number of pain killers, anti-asthmatic and anti-human immunodeficiency virus (HIV) drugs.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Zydus Lifesciences Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3.88 | 3.65 | 34.13 | 48.20 | 33.78 | 54.32 | 60.86 | 52.75 | 50.87 | 50.87 | ||||||||||
Raw Materials | 1.77 | 1.34 | 17.12 | 20.99 | 19.18 | 25.62 | 46.18 | 19.81 | 59.15 | 59.15 | ||||||||||
| Power & Fuel Cost | 2.87 | 0.70 | 8.62 | 11.70 | 10.28 | 15.91 | 22.23 | 14.80 | ||||||||||||
| Employee Cost | 5.67 | 5.63 | 11.49 | 14.41 | 14.56 | 15.30 | 14.96 | 15.54 | ||||||||||||
| Selling & Administrative Expenses | 3.13 | 2.52 | 3.43 | 3.83 | 4.01 | 3.39 | 6.11 | 4.57 | ||||||||||||
| Operating & Other expenses | 1.52 | 1.78 | 1.98 | 6.59 | 3.94 | 11.05 | 4.22 | 13.20 | ||||||||||||
EBITDA | -11.08 | -8.32 | -8.51 | -9.32 | -18.19 | -16.95 | -32.84 | -15.17 | -8.28 | -8.28 | ||||||||||
| Depreciation/Amortization | 4.49 | 4.23 | 4.15 | 4.40 | 4.68 | 5.12 | 6.30 | 6.56 | 6.77 | 6.76 | ||||||||||
| PBIT | -15.57 | -12.55 | -12.66 | -13.72 | -22.87 | -22.07 | -39.14 | -21.73 | -15.05 | -15.04 | ||||||||||
| Interest & Other Items | 0.74 | 3.49 | 5.17 | 6.29 | 6.00 | 6.28 | 5.39 | 2.97 | 4.69 | 4.69 | ||||||||||
| PBT | -16.31 | -16.04 | -17.83 | -20.01 | -28.87 | -28.35 | -44.53 | -24.70 | -19.74 | -19.73 | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| Net Income | -16.31 | -16.04 | -17.83 | -20.01 | -28.87 | -28.35 | -44.53 | -24.70 | -19.74 | -19.73 | ||||||||||
| EPS | -13.95 | -11.56 | -12.53 | -12.97 | -16.67 | -15.07 | -21.63 | -11.46 | -9.16 | -9.15 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Krebs Biochemicals and Industries Ltd | -10.36 | 6.70 | — |
| Sun Pharmaceutical Industries Ltd | 41.74 | 5.96 | 0.81% |
| Zydus Lifesciences Ltd | 31.44 | 5.49 | 0.25% |
| Cipla Ltd | 29.39 | 5.11 | 0.87% |
Price Comparison
Compare KREBSBIO with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
KREBSBIO has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeKrebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 7 August 2024.Powered by Capital Market - Live
Krebs Biochemicals & Industries Ltd leads gainers in ‘B’ group
North Eastern Carrying Corporation Ltd, Capital Trust Ltd, Kilitch Drugs (India) Ltd and Gujarat Raffia Industries Ltd are among the other gainers in the BSE's 'B' group today, 19 July 2024.Krebs Biochemicals & Industries Ltd soared 16.09% to Rs 118.84 at 12:02 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 1.47 lakh shares were traded on the counter so far as against the average daily volumes of 14701 shares in the past one month. North Eastern Carrying Corporation Ltd spiked 15.10% to Rs 36.06. The stock was the second biggest gainer in 'B' group. On the BSE, 4.15 lakh shares were traded on the counter so far as against the average daily volumes of 1.53 lakh shares in the past one month. Capital Trust Ltd surged 14.60% to Rs 136.95. The stock was the third biggest gainer in 'B' group. On the BSE, 85581 shares were traded on the counter so far as against the average daily volumes of 5237 shares in the past one month. Kilitch Drugs (India) Ltd exploded 10.00% to Rs 361.95. The stock was the fourth biggest gainer in 'B' group. On the BSE, 15931 shares were traded on the counter so far as against the average daily volumes of 1726 shares in the past one month. Gujarat Raffia Industries Ltd gained 9.99% to Rs 53.38. The stock was the fifth biggest gainer in 'B' group. On the BSE, 5819 shares were traded on the counter so far as against the average daily volumes of 5167 shares in the past one month. Powered by Capital Market - Live
Krebs Biochemicals & Industries Ltd leads gainers in ‘B’ group
Remedium Lifecare Ltd, Mahanagar Telephone Nigam Ltd, Coastal Corporation Ltd and Quick Heal Technologies Ltd are among the other gainers in the BSE's 'B' group today, 18 July 2024.Krebs Biochemicals & Industries Ltd spiked 20.00% to Rs 102.37 at 12:02 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 1.36 lakh shares were traded on the counter so far as against the average daily volumes of 7515 shares in the past one month. Remedium Lifecare Ltd surged 18.73% to Rs 19.02. The stock was the second biggest gainer in 'B' group. On the BSE, 48.35 lakh shares were traded on the counter so far as against the average daily volumes of 25.82 lakh shares in the past one month. Mahanagar Telephone Nigam Ltd soared 18.48% to Rs 63.21. The stock was the third biggest gainer in 'B' group. On the BSE, 72.37 lakh shares were traded on the counter so far as against the average daily volumes of 15.74 lakh shares in the past one month. Coastal Corporation Ltd gained 14.43% to Rs 282.7. The stock was the fourth biggest gainer in 'B' group. On the BSE, 90635 shares were traded on the counter so far as against the average daily volumes of 9778 shares in the past one month. Quick Heal Technologies Ltd exploded 12.96% to Rs 615.3. The stock was the fifth biggest gainer in 'B' group. On the BSE, 84325 shares were traded on the counter so far as against the average daily volumes of 14223 shares in the past one month. Powered by Capital Market - Live
Shashijit Infraprojects Ltd leads losers in ‘B’ group
Krebs Biochemicals & Industries Ltd leads gainers in ‘B’ group
Vesuvius India Ltd leads losers in ‘B’ group
5Paisa Capital Ltd leads gainers in ‘B’ group
Krebs Biochemicals & Industries reports standalone net loss of Rs 11.31 crore in the March 2022 quarter
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 1.08%, vs industry avg of 8.96%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.02% to 0.01%